Julie R. Boiko

Hematology | Oncology
4800 Sand Point Way NE
Seattle, WA 98105

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications

Shuffling the JAKs: playing a new card in chronic GVHD.

Shuffling the JAKs: playing a new card in chronic GVHD.

Journal: Blood advances
Published: August 27, 2026

Boosting "Treg-ulation": a good way to treat chronic GVHD?

Boosting "Treg-ulation": a good way to treat chronic GVHD?

Journal: Blood advances
Published: April 30, 2026

Spatial transcriptomics identifies a suppressive, T-cell excluded tumor microenvironment in extramedullary myeloma.

Spatial transcriptomics identifies a suppressive, T-cell excluded tumor microenvironment in extramedullary myeloma.

Journal: Blood advances
Published: March 23, 2026

Fear of Cancer Recurrence in Hematopoietic Cell Transplantation Survivors.

Fear of Cancer Recurrence in Hematopoietic Cell Transplantation Survivors.

Journal: Transplantation and cellular therapy
Published: January 14, 2026

Moving the needle on chronic GVHD of the lung.

Moving the needle on chronic GVHD of the lung.

Journal: Blood advances
Published: October 03, 2025

CSF-1R inhibition and lenalidomide synergize to promote myeloma control after autologous stem cell transplantation.

CSF-1R inhibition and lenalidomide synergize to promote myeloma control after autologous stem cell transplantation.

Journal: Blood
Published: June 02, 2025

CSF-1R inhibition and lenalidomide synergize to promote myeloma control after autologous stem cell transplantation.

CSF-1R inhibition and lenalidomide synergize to promote myeloma control after autologous stem cell transplantation.

Journal: Blood
Published: June 02, 2025

Chronic Graft-versus-host Disease: Immune Insights, Therapeutic Advances, and Parallels for Solid Organ Transplantation.

Chronic Graft-versus-host Disease: Immune Insights, Therapeutic Advances, and Parallels for Solid Organ Transplantation.

Journal: Transplantation
Published: December 17, 2024

Pediatric Transplant and Cellular Therapy Consortium RESILIENT Conference on Pediatric Chronic Graft-versus-Host Disease Survivorship after Hematopoietic Cell Transplantation: Part II. Organ Dysfunction and Immune Reconstitution Considerations for Children with Chronic Graft-versus-Host Disease after Hematopoietic Cell Transplantation.

Pediatric Transplant and Cellular Therapy Consortium RESILIENT Conference on Pediatric Chronic Graft-versus-Host Disease Survivorship after Hematopoietic Cell Transplantation: Part II. Organ Dysfunction and Immune Reconstitution Considerations for Children with Chronic Graft-versus-Host Disease after Hematopoietic Cell Transplantation.

Journal: Transplantation and cellular therapy
Published: September 25, 2024

Defining pathogenic IL-17 and CSF-1 gene expression signatures in chronic graft-versus-host disease.

Defining pathogenic IL-17 and CSF-1 gene expression signatures in chronic graft-versus-host disease.

Journal: Blood
Published: May 08, 2024

TIM-3+ CD8 T cells with a terminally exhausted phenotype retain functional capacity in hematological malignancies.

TIM-3+ CD8 T cells with a terminally exhausted phenotype retain functional capacity in hematological malignancies.

Journal: Science immunology
Published: April 19, 2024

Decreasing chronic graft-versus-host disease rates in all populations.

Decreasing chronic graft-versus-host disease rates in all populations.

Journal: Blood advances
Published: January 22, 2024
Showing 1-12 of 17

Last Updated: 09/26/2026